A phase I/II study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors Meeting Abstract

  

Authors:	Dela Cruz, F. S.; Fox, E.; Muscal, J. A.; Kirov, I.; Geller, J. I.; DuBois, S. G.; Kim, A.; Croop, J.; Laetsch, T. W.; Minard, C. G.; Liu, X. W.; Weigel, B.; Okpara, C. E.; Huang, J.; Dutta, L.; Aluri, J.; Glade Bender, J. L.
Abstract Title:	A phase I/II study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors
Meeting Title:	56th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	38
Issue:	15 Suppl.
Meeting Dates:	2020 May 29-31
Meeting Location:	Virtual
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2020-05-20
Start Page:	530s
Language:	English
ACCESSION:	WOS:000560368300245
PROVIDER:	wos
DOI:	10.1200/JCO.2020.38.15_suppl.10527
Notes:	Meeting Abstract: 10527 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/172851